Food and Drug Administration

Advisory Committee for Pharmaceutical Science

October 25-26, 2005

FDA Briefing Information

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. 552).
These redacted portions will appear as white space on the screen or on the printed page.

Table of Contents for FDA Backgrounder